Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Sponsored by Altamash Institute of Dental Medicine
About this trial
Last updated 3 years ago
Study ID
Treatment of OSF stage 2 and 3
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
All
All
Trial Timing
Ended 4 years ago
What is this trial about?
To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with
stage two and three oral submucous fibrosis.
What are the participation requirements?
Inclusion Criteria
- Patients with clinically diagnosed OSMF who have not undergone any treatment of OSMF in past
- Patients willing to quit their tobacco chewing habit, gutkha areca nut smoking
- Patients who are ready to attend regular follow-ups
Exclusion Criteria
- Patients who have undergone any treatment for OSF in past
- Patients with any evidence of cardiac, gastrointestinal, kidney, metabolic disorders, pregnant and lactating women's
- Patients with any co-existing disorder of the orofacial region other than OSF which may interfere with the study protocol